Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study.

Zivadinov, Robert; Pei, Jinglan; Clayton, David; Goldman, Donna E; Winger, Ryan C; Cabatingan, Mark S; Dwyer, Michael G; Bergsland, Niels.

Zivadinov R; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA Rzivadinov@bnac.net.
Pei J; Center for Biomedical Imaging at Clinical Translational Science Institute, University at Buffalo, State University of New York, Buffalo, NY, USA.
Clayton D; Genentech Inc, South San Francisco, CA, USA.
Goldman DE; Genentech Inc, South San Francisco, CA, USA.
Winger RC; Genentech Inc, South San Francisco, CA, USA.
Cabatingan MS; Genentech Inc, South San Francisco, CA, USA.
Dwyer MG; Genentech Inc, South San Francisco, CA, USA.
Bergsland N; Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, USA.

J Neurol Neurosurg Psychiatry ; 2023 Dec 06.

Article en En | MEDLINE | ID: mdl-38071574